Accounting Manager, R&D

Overview of Role

The Accounting Manager (R&D) will be an integral member of the Accounting team, primarily focused on accounting for the Company’s multiple ongoing and planned clinical trials. You will focus on the preparation of monthly journal entries and ensuring completeness and accuracy of the Company’s clinical trial-related expenses. In this role, you will assist in analyzing the monthly clinical trial expenses, working with the clinical operations team and third-party vendors. Attention to detail and adherence to ongoing deadlines will be important for success in this role.

About Summit

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

• HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
• HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
• HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
• HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Note: Text within emphasis tags has been kept for context but the emphasis formatting has been removed as part of formatting refinement.

Role and Responsibilities

• Support the monthly close process to ensure timely and accurate financial reporting, with a focus on continuous process improvement and reducing close timelines
• Prepare and review high visibility CRO entries, Investigator Grant entries, and other R&D entries
• Own/review the accounting and financial tracking for clinical trial accruals, working closely with cross-functional teams to ensure the data is complete, accurate, and audit-compliant
• Lead site payments process with 3 rd party vendor clinical sites by reviewing invoices, checking them against Clinical Trial Agreements (CTAs), working with the Clinical Operations team and resolving any issues quickly and timely
• Collaborate cross-functionally with other teams like Clinical Operations, Vendor Management and Legal to support strategic business objectives and ensure the accuracy of financial information
• Maintain and monitor SOX controls related to operational accounting are completed on time and are working as intended. Proactively identify and escalate any control deficiencies
• Support financial systems optimization and upgrades, including implementing systems/tools and making the most of Netsuite and Coupa
• Assist with audit preparation by gathering needed documents, preparing schedules (PBCs), and responding to audit requests
• All other duties as assigned

Experience, Education and Specialized Knowledge and Skills

• Bachelor’s degree in finance, business, accounting or related field preferred
• A minimum of 5+ years of experience in accounting /finance
• Experience in the life sciences industry, with prior exposure to clinical study accruals strongly preferred
• Experience in FP&A, including budgeting, forecasting, variance analysis, and financial modeling
• Strong understanding of GAAP, internal controls, SOX controls and month-end close procedures required
• Must be proficient in handling large-scale financial data using Excel and financial systems for accurate analysis and reporting
• High level of accuracy and attention to detail
• Demonstratable experience of working within a fast-paced finance function
• Demonstratable experience of prioritizing workload and managing multiple tight deadlines effectively under pressure in a fast-paced environment
• Excellent communication skills with the ability to forge strong internal and external working relationships, and the confidence to challenge information constructively
• Enthusiastic team player with an approachable manner and an ability to engage with colleagues across the business with a constructive and can-do attitude to deliver the successful completion of team outputs within required deadlines

The pay range for this role is $139,000-$163,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at [email protected] to obtain prior written authorization before referring any candidates to Summit.